Company Filing History:
Years Active: 2017-2024
Title: Mats Eskil Elmér: Innovator in Succinate Prodrug Development
Introduction
Mats Eskil Elmér is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of succinate prodrugs. With a total of 3 patents, his work focuses on enhancing mitochondrial ATP production, which has implications for various medical treatments.
Latest Patents
Elmér's latest patents include a novel isolated succinate prodrug, which can exist as a free compound or in various forms such as salts, hydrates, solvates, or complexes. This compound is designed to be cell permeable and aims to increase ATP production in mitochondria. The applications of this invention extend to medical treatments for a range of diseases, as well as uses in nutritional supplements, nutricosmetics, and cosmetics.
Career Highlights
Mats Eskil Elmér is associated with Abliva AB, a company focused on developing innovative treatments for mitochondrial diseases. His work at Abliva has positioned him as a key player in the field of mitochondrial research and therapy.
Collaborations
Elmér has collaborated with notable colleagues such as Magnus Joakim Hansson and Alvar Grönberg, contributing to the advancement of research in his area of expertise.
Conclusion
Mats Eskil Elmér's innovative work in succinate prodrug development showcases his commitment to improving medical treatments and enhancing human health. His contributions are paving the way for future advancements in biochemistry and medicine.